Jimmy J. Hwang

机构：Carolinas Healthcare System, Levine Cancer Institute

发表论文 331 篇 · 总被引 6590 次 · h-index 39

代表论文

• Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study (2024 · Journal of Clinical Oncology · 被引 23)
• Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of response (2024 · BJC Reports · 被引 19)
• Real-World Impact of an In-House Dihydropyrimidine Dehydrogenase ( DPYD ) Genotype Test on Fluoropyrimidine Dosing, Toxicities, and Hospitalizations at a Multisite Cancer Center (2024 · JCO Precision Oncology · 被引 16)
• Addressing barriers to increased adoption of DPYD genotyping at a large multisite cancer center (2023 · American Journal of Health-System Pharmacy · 被引 14)
• Role of CD47 gene expression in colorectal cancer: a comprehensive molecular profiling study (2024 · Journal for ImmunoTherapy of Cancer · 被引 9)
• Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer (2024 · npj Precision Oncology · 被引 9)